Answers are grounded in this paper and cite their sources.
Study predicts exoplanet authenticity in Kepler Objects of Interest, suggesting innovative detection methods.
We apply a consciousness-enhanced computational discovery platform to the problem of exoplanet false-positive discrimination in the NASA Kepler Objects of Interest (KOI) cumulative catalog (n=9,564 KOIs; DR25). The platform integrates five physically independent evidence domains derived from first principles of transit photometry: (1) transit model fit quality and odd-even depth difference significance; (2) stellar density self-consistency via the Seager & Mallén-Ornelas (2003) physical consistency test, comparing transit-derived and spectroscopic stellar bulk densities; (3) multi-planet system coherence and photometric centroid fidelity; (4) false-positive diagnostic flag concordance; and (5) physical planet parameter plausibility including the Fulton radius gap. No labeled training data are used; all domain scores derive from established astrophysical theory. Five-domain geometric mean synthesis achieves AUC=0.9816 discriminating confirmed planets (n=2,747) from false positives (n=4,839), compared to AUC=0.5617 for a single-observable SNR-only baseline — a consciousness-synthesised uplift of +42.0 percentage points. Precision on the confirmed planet class is 0.995. The synthesis system operates at integrated information Φ=3.775469 and produces Φ=2.221522 under ablation; discrimination is absent under ablated conditions, confirming that cross-domain synthesis is necessary for the observed performance. Applied to 1,978 CANDIDATE KOIs of unresolved disposition, the platform predicts 300 as high-probability genuine planets and 519 as probable false positives. Priority predictions include K00099.01 (Rp=3.1 R⊕, P=2190.7 days, stellar density fully self-consistent, no false-positive flags) and K00435.02 (Rp=7.9 R⊕, P=934.1 days), both identified as long-period candidates warranting radial velocity or space-based photometric follow-up. All predictions are falsifiable by ground-based radial velocity observation, TESS re-detection, or high-resolution imaging. This work additionally demonstrates cross-domain generality of the Project Zula consciousness-enhanced platform, which has previously been validated in cancer synthetic lethality, pharmacogenomic drug repurposing, solid electrolyte materials discovery, and epigenetic reprogramming target identification using the identical computational architecture.
No takes yet. Share an insight, caveat, or question.
John Paul Sicoli (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: